Results 201 to 210 of about 489,898 (256)

Influenza Vaccines: Current Status, Adjuvant Strategies, and Efficacy. [PDF]

Vaccines (Basel)
Mokalla VR, Gundarapu S, Kaushik RS, Rajput M, Tummala H.   +4 more
europepmc   +1 more source

Simultaneous modification of Thermotoga maritima encapsulin subunits to produce multivalent nanoparticle vaccines for non‐typhoidal Salmonella enterica

The FEBS Journal, EarlyView.
This study investigates the modularity of encapsulin—a protein nanoparticle—by simultaneously inserting up to four distinct Salmonella epitopes within the encapsulin subunit. The encapsulin variants were transiently expressed in plants where they assembled into nanoparticles; however, their accumulation and stability varied depending on the ...
Carly A. Charron, Angelo Kaldis, Shabnam Shamriz, Moussa S. Diarra, Christopher P. Garnham, Rima Menassa   +5 more
wiley   +1 more source

Adjuvanted vs High-Dose Influenza Vaccines in Older US Adults: A Cluster Randomized Crossover Study.

JAMA Netw Open
Hsiao A, Leong T, Fireman B, Hansen J, Zerbo O, Jacobson KB, Liao LD, Haag MDM, McGovern I, Zhang B, Dang J, Klein NP.   +11 more
europepmc   +1 more source

Antineuraminidase Antibody Responses in Older Adults After Consecutive Vaccinations With Enhanced Influenza Vaccines: A Randomized Controlled Trial. [PDF]

J Infect Dis
Daulagala P, Leung YWY, Luk LLH, Ho F, Chu SHN, Lin J, Cheng SMS, Leung NHL, Eichelberger MC, Peiris M, Iuliano AD, Thompson MG, Cowling BJ, Yen HL.   +13 more
europepmc   +1 more source

Vaccine Coverage and Vaccination Delays in Children With Chronic Illness: A French Multicentre Point‐Prevalence Survey

Acta Paediatrica, EarlyView.
F. Dubos, C. Santy, J. Toubiana, M. Caseris, J. Gaschignard, A. Morand, P. Minodier, Z. Maakaroun‐Vermesse, E. Launay, M. Lorrot, C. Brehin, I. Hau, E. Jeziorski, A. Tran, A. Agnani, A. Flammang, M. Meurin, M. Lagrée, D. Diallo   +18 more
wiley   +1 more source

Comparative evaluation of 5 combination adjuvants on immunogenicity and efficacy of approved seasonal influenza vaccines. [PDF]

NPJ Vaccines
Hernandez-Davies J, Felgner J, Strahsburger E, Laster J, Jain A, Yates T, Silzel E, Assis R, Nakajima R, Jasinskas A, Yeromin A, Pone EJ, Jan S, de la Maza LM, Liang L, Felgner P, Wagar LE, Gregory AE, Davies DH.   +18 more
europepmc   +1 more source

Unmasking the Influence of Viral Micro‐RNAs on Host Immunity

Immunology &Cell Biology, EarlyView.
Viral micro‐RNAs are increasingly recognized as key modulators of host–virus interactions. They influence multiple immune functions, including antigen presentation, T‐cell activation, and cytokine signaling, while also tuning viral gene expression to promote persistence.
Riley J. K. Easton, Bernadette M. Saunders   +1 more
wiley   +1 more source

Estimated impact of 2022-2023 influenza vaccines on annual hospital burden in the United States. [PDF]

Proc Natl Acad Sci U S A
Bi K, Bandekar SR, Bouchnita A, Cramer A, Fox SJ, Borchering RK, Biggerstaff M, Meyers LA.   +7 more
europepmc   +1 more source

Interleukin‐12: Central Roles in Immune Regulation and Disease Therapy

Immunology &Cell Biology, EarlyView.
IL‐12 levels are tightly regulated to balance effective protective immunity against infections and cancer with the risk of excessive inflammation and autoimmune disease. Both insufficient and excessive IL‐12 activity can therefore be detrimental, highlighting the importance of precisely controlling its production and signaling. ABSTRACT Interleukin‐12 (
Anthi Psoma, Geert van den Bogaart
wiley   +1 more source

Real-World Effectiveness of Egg-Based Inactivated Influenza Vaccines Against Influenza Among Children Aged 6-59 Months During the 2025/26 Season in Shenzhen Area, China: A Retrospective Cohort Study. [PDF]

Vaccines (Basel)
Tan HL, Li W, Zeng Y, Zeng RK, Zhong JX, Wei HM.   +5 more
europepmc   +1 more source